Can a diabetes drug reveal hidden hormone deficiencies?
NCT ID NCT04897802
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether people with hypopituitarism (a condition where the pituitary gland doesn't work properly) have lower oxytocin levels compared to healthy individuals. Researchers gave participants a drug called exenatide (a GLP1 receptor agonist) to see if it could stimulate oxytocin release. The goal was to better understand oxytocin deficiency in these patients, not to treat it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL DIABETES INSIPIDUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08041, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI chat could be a secret weapon against dementia in lonely seniors
- Beyond breathing: could an asthma drug lift emotional burdens for patients and partners?
- Weekly shot could replace daily needles for kids with growth hormone deficiency
- Weekly shot could replace daily growth hormone injections for children
- Weekly shot could replace daily needles for kids with growth hormone deficiency
- Can a Peer-Led program break the cycle of social isolation in veterans?